← Back to Search

Other

Dietary Protein Patterns for Parkinson's Disease

N/A

Recruiting

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Clinical diagnosis of idiopathic PD for 5 or more years

45 years or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 5 weeks. total score ranges from 0-260 with higher scores indicating greater symptom severity.

Awards & highlights

Study Summary

This trial will study the effects of different dietary protein patterns on people with Parkinson's disease.

Who is the study for?

This trial is for people over 45 with Parkinson's Disease diagnosed at least 5 years ago, who are on stable levodopa treatment and have motor fluctuations. It's not for those on special diets, with renal disease, deep brain stimulation, narcolepsy, untreated sleep apnea or any condition that might interfere with the study.Check my eligibility

What is being tested?

The study tests how different protein diets affect muscle health and medication effectiveness in Parkinson's patients. One group will follow a Protein Redistribution Diet while another will maintain a consistent protein intake to see which is better.See study design

What are the potential side effects?

Since this trial involves dietary changes rather than medications, side effects may include digestive discomfort or changes in energy levels as the body adjusts to new eating patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with Parkinson's disease for 5 or more years.

Select...

I am 45 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 5 weeks. total score ranges from 0-260 with higher scores indicating greater symptom severity.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 5 weeks. total score ranges from 0-260 with higher scores indicating greater symptom severity.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 5 weeks. total score ranges from 0-260 with higher scores indicating greater symptom severity. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in handgrip strength

Body Weight Changes

Change in markers of skeletal muscle metabolism GDF15

+2 more

Secondary outcome measures

Change in physical activity

Change in total Parkinson symptoms

Trial Design

2Treatment groups

Active Control

Group I: Protein Redistribution DietActive Control1 Intervention

PD participants may first be randomized to follow the Protein Redistribution Diet followed by the Protein Consistent Diet.

Group II: Protein Consistent DietActive Control1 Intervention

PD participants may first be randomized to follow the Protein Consistent Diet followed by the Protein Redistribution Diet.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor

1,590 Previous Clinical Trials

2,281,462 Total Patients Enrolled

Media Library

Protein Redistribution Diet (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05437640 — N/A

Parkinson's Disease Research Study Groups: Protein Redistribution Diet, Protein Consistent Diet

Parkinson's Disease Clinical Trial 2023: Protein Redistribution Diet Highlights & Side Effects. Trial Name: NCT05437640 — N/A

Protein Redistribution Diet (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05437640 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current openings to join the trial?

"Correct. The records available on clinicaltrials.gov establish that this medical investigation, which was first uploaded on October 1st 2022, is actively enrolling individuals. Approximately 20 people need to be admitted from a single trial site."

Answered by AI

Is the age-limit for applicants of this trial inclusive to those in their eighties?

"This medical trial is accessible to patients between 45 and 99 years old. Patients younger than 18 can consult the 27 studies available to them, while those older than 65 may wish to consider one of the 486 other trials."

Answered by AI

Are my particulars suitable for entry into this experiment?

"Candidates for this medical research must have Parkinson's disease and be between 45 to 99 years of age. Currently, the intention is to recruit an aggregate of 20 participants in total."

Answered by AI

What is the estimated number of participants in this research project?

"Affirmative. According to clinicaltrials.gov, this medical experiment is actively enrolling participants and was initially posted on October 1st 2022. The last update occurred three days later on the 3rd of the same month, with 20 individuals needed from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Optimizing Protein Patterns for Skeletal Muscle Preservation and Sleep in the Medical Management of Parkinson Disease

Christine Ferguson, PhD, RD, LD 2022. "Optimizing Protein Patterns for Skeletal Muscle Preservation and Sleep in the Medical Management of Parkinson Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05437640.